Cue Biopharma, Inc. (CUE)
27.44
-0.23
(-0.83%)
USD |
NASDAQ |
Sep 04, 16:00
27.34
-0.10
(-0.36%)
Pre-Market: 20:00
Cue Biopharma SG&A Expense (TTM) : 59.11M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.11M |
| March 31, 2026 | 16.22M |
| December 31, 2025 | 16.24M |
| September 30, 2025 | 16.81M |
| June 30, 2025 | 14.74M |
| March 31, 2025 | 14.57M |
| December 31, 2024 | 14.58M |
| September 30, 2024 | 15.17M |
| June 30, 2024 | 15.95M |
| March 31, 2024 | 16.69M |
| December 31, 2023 | 16.68M |
| September 30, 2023 | 15.77M |
| June 30, 2023 | 15.66M |
| March 31, 2023 | 15.19M |
| December 31, 2022 | 16.17M |
| September 30, 2022 | 17.11M |
| June 30, 2022 | 17.71M |
| March 31, 2022 | 18.21M |
| December 31, 2021 | 17.31M |
| Date | Value |
|---|---|
| September 30, 2021 | 16.11M |
| June 30, 2021 | 15.30M |
| March 31, 2021 | 14.92M |
| December 31, 2020 | 14.65M |
| September 30, 2020 | 14.31M |
| June 30, 2020 | 13.76M |
| March 31, 2020 | 13.28M |
| December 31, 2019 | 12.74M |
| September 30, 2019 | 14.11M |
| June 30, 2019 | 14.23M |
| March 31, 2019 | 13.04M |
| December 31, 2018 | 11.30M |
| September 30, 2018 | 8.247M |
| June 30, 2018 | 6.382M |
| March 31, 2018 | 4.776M |
| December 31, 2017 | 3.073M |
| September 30, 2017 | 1.654M |
| September 30, 2016 | 0.6242M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Fortress Biotech, Inc. | 68.84M |
| Equillium, Inc. | 10.72M |
| Legend Biotech Corp. | 376.01M |
| Nurix Therapeutics, Inc. | 57.01M |